home / stock / aldx / aldx short
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 3,258,008 |
Total Actual Volume | 27,736,604 |
Short Trends | |
---|---|
Cover Days | 6 |
Short Days | 11 |
No Change Days | 3 |
Averages | |
---|---|
Average Short Volume | 162,900 |
Average Short Percentage | 46.32% |
Is there a ALDX Short Squeeze or Breakout about to happen?
See the ALDX Short Analysis for free Sign up or Login
Powered by Squeeze Report
Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
2022-07-05 | 3.73 | 4.03 | 4.055 | 3.68 | 546,876 | 38,834 | 27.5440 |
2022-06-30 | 3.81 | 3.99 | 4.04 | 3.81 | 570,472 | 42,334 | 20.0073 |
2022-06-29 | 3.96 | 3.93 | 4.01 | 3.81 | 656,021 | 46,637 | 19.0175 |
2022-06-28 | 3.95 | 3.99 | 4.04 | 3.8703 | 784,331 | 63,599 | 25.3433 |
2022-06-27 | 3.78 | 3.87 | 3.93 | 3.58 | 1,046,390 | 62,252 | 23.6837 |
2022-06-24 | 3.62 | 3.68 | 3.74 | 3.43 | 6,570,174 | 122,919 | 40.3439 |
2022-06-23 | 3.17 | 3.59 | 3.64 | 3.17 | 1,220,759 | 166,752 | 47.7052 |
2022-06-22 | 3.14 | 3.17 | 3.355 | 3.08 | 1,227,896 | 123,313 | 46.7378 |
2022-06-21 | 3.44 | 3.18 | 3.45 | 3.16 | 1,411,652 | 299,694 | 61.3246 |
2022-06-16 | 3.28 | 3.3 | 3.33 | 3.1534 | 895,061 | 122,842 | 74.9384 |
2022-06-15 | 3.5 | 3.37 | 3.53 | 3.265 | 825,567 | 168,001 | 55.7136 |
2022-06-14 | 3.25 | 3.46 | 3.545 | 3.25 | 760,090 | 125,344 | 53.9402 |
2022-06-13 | 3.41 | 3.34 | 3.535 | 3.28 | 1,145,897 | 205,039 | 58.2605 |
2022-06-09 | 3.59 | 3.86 | 4.03 | 3.42 | 2,782,534 | 643,610 | 64.8073 |
2022-06-08 | 3.85 | 3.5 | 3.87 | 3.46 | 5,048,407 | 692,082 | 60.2436 |
2022-06-06 | 3.13 | 3.21 | 3.28 | 3.07 | 529,224 | 86,572 | 55.0464 |
2022-06-03 | 3.05 | 3.05 | 3.1769 | 3 | 546,429 | 43,753 | 25.3655 |
2022-06-02 | 2.93 | 3.06 | 3.1 | 2.88 | 364,096 | 74,149 | 55.8852 |
2022-06-01 | 3.09 | 2.94 | 3.17 | 2.86 | 437,949 | 79,055 | 53.0261 |
2022-05-31 | 3.1 | 3.09 | 3.17 | 3.01 | 366,779 | 51,227 | 57.3998 |
Aldeyra Therapeutics Inc. Company Name:
ALDX Stock Symbol:
NASDAQ Market:
Aldeyra Therapeutics Inc. Website:
News, Short Squeeze, Breakout and More Instantly...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra), a biotechnology company developing innovative therapies for the treatment of immune-mediated diseases, today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer of Aldeyra, will participate in a firesi...
Reproxalap Statistically Superior to Vehicle for Both Prespecified Primary Endpoints of Schirmer Test (p=0.0001) and ≥10 mm Schirmer Test Responder Proportions (p<0.0001) TRANQUILITY-2 Results May Allow for the Most Comprehensive Dry Eye Disease New Drug Applicatio...
Aldeyra Therapeutics, Inc. (Nasdaq: ALDX) (Aldeyra) today announced it will host a webcast and conference call on Wednesday, June 8, 2022, at 8:00 a.m. (ET) to provide top-line results from the Phase 3 TRANQUILITY-2 Trial of reproxalap in dry eye disease. The dial-in numbers are...